Skip to content

Anesthesia Effects of Superior Laryngeal Nerve Block Combined with Remimazolam in Elderly Hypertensive Patients Undergoing Bronchoscopy

Anesthesia Effects of Superior Laryngeal Nerve Block Combined with Remimazolam in Elderly Hypertensive Patients Undergoing Bronchoscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121168
Enrollment
Unknown
Registered
2026-03-26
Start date
2025-03-02
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Group receiving superior laryngeal nerve block combined with remimazolam:Supraclavicular nerve block combined with remifentanil for induction anesthesia
Remimazolam Group:Remimazolam-induced anesthesia
Propofol Group:Propofol-induced anesthesia
Lidocaine Nebulization Inhalation Group:Routine lidocaine nebulization inhalation

Sponsors

The First Hospital of Shanxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing flexible bronchoscopy 2. Age 60–75 years; 3. Patients agree to and accept nerve block; 4. Preoperative hypertension (blood pressure maintained at 130–160 mmHg); 5. ASA class II–III

Exclusion criteria

Exclusion criteria: 1. Infectious wounds on the neck 2. Significant coagulation dysfunction 3. Allergy to local anesthetics 4. Those with upper respiratory tract infections, chronic pharyngitis, or sore throat 5. Individuals with oral anatomical abnormalities 6. Hoarseness before examination 7. Patients with dysfunction of important organs such as heart, lungs, liver, or kidneys 8. Patients with secondary hypertension 9. Patients with cognitive impairment 10. Alcoholics or drug users, patients with epilepsy or mental illness

Design outcomes

Primary

MeasureTime frame
Mean arterial pressure;Heart rate;Blood Oxygen Saturation;

Secondary

MeasureTime frame
Cortisol concentration;Number of adverse reactions;

Countries

China

Contacts

Public ContactYang Ling

Department of Anesthesiology, The First Hospital of Shanxi Medical University

YL1362367@163.com+86 351 463 9683

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 4, 2026